CME Group Inc.
DE ˙ XTRA ˙ US12572Q1058
217,80 € ↑3,15 (1,47%)
2026-06-03
AKTIENPREIS
SecurityDE:MX4A / CME Group Inc.
InstitutionSignaturefd, Llc
Latest Disclosed Ownership6,584 shares
Latest Disclosed Value $ 1,944,635
Signaturefd, Llc reports 0.43% increase in ownership of MX4A / CME Group Inc.

On April 7, 2026 - Signaturefd, Llc filed a 13F-HR form disclosing ownership of 6,584 shares of CME Group Inc. (DE:MX4A) valued at $1,681,883 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 20, 2026 disclosing 6,556 shares of CME Group Inc.. This represents a change in shares of 0.43% during the quarter. The current value of the position is $1,433,995 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-07 2026-03-31 13F CME GROUP COM 12572Q105 6,584 28 0.43 1,945 8.60 0.0298
2026-01-20 2025-12-31 13F CME GROUP COM 12572Q105 6,556 239 3.78 1,790 4.92 0.0273
2025-10-21 2025-09-30 13F CME GROUP COM 12572Q105 6,317 -12 -0.19 1,707 -2.18 0.0269
2025-07-16 2025-06-30 13F CME GROUP COM 12572Q105 6,329 871 15.96 1,744 20.44 0.0297
2025-05-02 2025-03-31 13F CME GROUP COM 12572Q105 5,458 204 3.88 1,448 18.69 0.0274
2025-02-10 2024-12-31 13F CME GROUP COM 12572Q105 5,254 457 9.53 1,220 15.31 0.0231
2024-10-21 2024-09-30 13F CME GROUP COM 12572Q105 4,797 -11 -0.23 1,059 11.96 0.0202
2024-07-29 2024-06-30 13F CME GROUP COM 12572Q105 4,808 -328 -6.39 945 -14.48 0.0192
2024-05-03 2024-03-31 13F CME GROUP COM 12572Q105 5,136 -258 -4.78 1,106 -2.73 0.0234
2024-02-01 2023-12-31 13F CME GROUP COM 12572Q105 5,394 392 7.84 1,136 13.49 0.0262
2023-11-03 2023-09-30 13F CME GROUP COM 12572Q105 5,002 525 11.73 1,002 20.75 0.0261
2023-08-01 2023-06-30 13F CME GROUP COM 12572Q105 4,477 -497 -9.99 830 -12.92 0.0212
2023-04-28 2023-03-31 13F CME GROUP COM 12572Q105 4,974 1,325 36.31 953 55.30 0.0260
2023-01-30 2022-12-31 13F CME GROUP COM 12572Q105 3,649 179 5.16 614 -0.33 0.0179
2022-11-08 2022-09-30 13F CME GROUP COM 12572Q105 3,470 451 14.94 615 -0.49 0.0211
2022-08-10 2022-06-30 13F CME GROUP COM 12572Q105 3,019 232 8.32 618 -6.79 0.0210
2022-05-02 2022-03-31 13F CME GROUP COM 12572Q105 2,787 419 17.69 663 22.55 0.0200
2022-01-25 2021-12-31 13F CME GROUP COM 12572Q105 2,368 147 6.62 541 25.81 0.0166
2021-10-28 2021-09-30 13F CME GROUP COM 12572Q105 2,221 247 12.51 430 2.38 0.0149
2021-07-26 2021-06-30 13F CME GROUP COM 12572Q105 1,974 377 23.61 420 28.83 0.0168
2021-04-30 2021-03-31 13F CME GROUP COM 12572Q105 1,597 268 20.17 326 34.71 0.0144
2021-02-11 2020-12-31 13F CME GROUP COM 12572Q105 1,329 -117 -8.09 242 0.00 0.0114
2020-11-03 2020-09-30 13F CME GROUP COM 12572Q105 1,446 -97 -6.29 242 -3.59 0.0130
2020-07-30 2020-06-30 13F CME GROUP COM 12572Q105 1,543 -552 -26.35 251 -30.66 0.0152
2020-04-23 2020-03-31 13F CME GROUP COM 12572Q105 2,095 253 13.74 362 -2.16 0.0313
2020-02-05 2019-12-31 13F CME GROUP COM 12572Q105 1,842 31 1.71 370 -3.39 0.0273
2019-10-16 2019-09-30 13F CME GROUP COM 12572Q105 1,811 467 34.75 383 46.74 0.0315
2019-07-31 2019-06-30 13F CME GROUP COM 12572Q105 1,344 8 0.60 261 18.64 0.0226
2019-05-09 2019-03-31 13F CME GROUP COM CL A 12572Q105 1,336 -308 -18.73 220 -28.80 0.0187
2019-02-13 2018-12-31 13F CME GROUP COM CL A 12572Q105 1,644 192 13.22 309 25.10 0.0288
2018-11-14 2018-09-30 13F CME GROUP COM CL A 12572Q105 1,452 106 7.88 247 11.76 0.0251
2018-08-14 2018-06-30 13F CME GROUP COM CL A 12572Q105 1,346 492 57.61 221 60.14 0.0247
2018-05-08 2018-03-31 13F CME GROUP COM CL A 12572Q105 854 -3 -0.35 138 53.33 0.0162
2016-11-14 2016-09-30 13F CME GROUP COM 12572Q105 857 504 142.78 90 164.71 0.0131
2016-07-29 2016-06-30 13F CME GROUP COM 12572Q105 353 119 50.85 34 54.55 0.0050
2016-05-12 2016-03-31 13F CME GROUP COM 12572Q105 234 138 143.75 22 144.44 0.0038
2016-01-22 2015-12-31 13F CME GROUP COM 12572Q105 96 22 29.73 9 28.57 0.0017
2015-10-23 2015-09-30 13F CME GROUP COM 12572Q105 74 54 270.00 7 250.00 0.0016
2015-07-15 2015-06-30 13F CME GROUP COM 12572Q105 20 20 0.00 2 0.0004
2014-08-14 2014-06-30 13F CME GROUP COM 12572Q105 0 -72 -100.00 0 -100.00
2014-05-16 2014-03-31 13F CME GROUP COM 12572Q105 72 72 5 0.0020
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.